You are now visiting tipharma.com.
On 1 January, 2016, TI Pharma and CTMM merged
to form a new organization called Lygature.
Please note that information on the tipharma.com site has not
been updated since, and is retained as an archive.
For up-to-date information, please visit lygature.org.
6th edition of TI Pharma Spring Meeting: all about Inspiring Healthy Partnerships!
Healthy multidisciplinary partnerships have the potential to create necessary solutions for global health challenges. TI Pharma continues to enable excellent pharmaceutical research in the current open innovation environment. At the Spring Meeting a few examples of newly formed international partnerships in the field of drug discovery and development were presented. These partnerships are able to address scientific challenges which would not be achievable for a single organization.
"The state of the art HTS robotics of Pivot Park Screening Centre are key in finding novel hits in early drug discovery."
"It is not the disease that is neglected but the people. Schistosomiasis has a severe impact on the overall health of children in the developing world. This problem can only be addressed when partners with specific tasks and expertise collaborate successfully."
"More and more Health Foundations play an active role in public-private partnerships. They are essential for us to be able to focus on translating the best science into viable clinical concepts that will bring solutions for patients."
New! Year in Review 2013 magazine lists recent achievements in the Dutch Life Sciences & Health sector
The Dutch Life Sciences and Health sector is one of the most concentrated high performing clusters in the world. The combination of a strategic location within Europe, strong collaboration between world-class universities, industry and government, and a highly educated multilingual workforce offers the necessary climate for growth.
Learn more about the Dutch Life Sciences & Health cluster in the Year in Review magazine 2013.
TI Pharma fellow Saskia Overbeek nominated to participate in the Eureka 5th Annual International Certificate Program in Translational Medicine
Identifying talent has always been part of the TI Pharma strategy. Stimulating and promoting our fellows in their future professional career is a continuous objective.
Enroll for the TI Pharma workshop 'Animal-free safety testing of new medicines' - Thursday, May 23rd, 2013 - Centraal Museum Utrecht
Gain new insights into the future of drug development without the use of animals for safety testing. Is it possible to transition towards such a situation?
Learn about the recently obtained results from the TI Pharma project on the predictive value of animal testing in pharmaceuticals and how this had led to new scientific insights.
The program includes lectures from scientists of the University of Utrecht and Nefarma, and a panel discussion with experts from industry, the regulatory authorities and academia.
For a full description of the workshop and registration procedure, please click here.
Registration for FIGON Dutch Medicines Days 2013 is open!
Meet partners involved in drug research, exchange knowledge and share new scientific insights at this year's FIGON Dutch Medicine Days. The meeting will be held from September 30th to October 2nd in venue De Reehorst in Ede.